Commentary: Why Haven’t We Found an Effective Treatment for COVID-19?
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Frontiers in Immunology - 12(2021) |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Josef Brzoska [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
COVID-19 |
---|
doi: |
10.3389/fimmu.2021.714175 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ06885594X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ06885594X | ||
003 | DE-627 | ||
005 | 20230502121958.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fimmu.2021.714175 |2 doi | |
035 | |a (DE-627)DOAJ06885594X | ||
035 | |a (DE-599)DOAJ3859247c2fa14facad3f744a2d54211d | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC581-607 | |
100 | 0 | |a Josef Brzoska |e verfasserin |4 aut | |
245 | 1 | 0 | |a Commentary: Why Haven’t We Found an Effective Treatment for COVID-19? |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
650 | 4 | |a COVID-19 | |
650 | 4 | |a coronavirus | |
650 | 4 | |a interferons - pharmacology | |
650 | 4 | |a therapeutic use | |
650 | 4 | |a corticosteroids | |
650 | 4 | |a clinical trials | |
653 | 0 | |a Immunologic diseases. Allergy | |
700 | 0 | |a Harald von Eick |e verfasserin |4 aut | |
700 | 0 | |a Manfred Hündgen |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Frontiers in Immunology |d Frontiers Media S.A., 2011 |g 12(2021) |w (DE-627)DOAJ000031690 |x 16643224 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2021 |
856 | 4 | 0 | |u https://doi.org/10.3389/fimmu.2021.714175 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/3859247c2fa14facad3f744a2d54211d |z kostenfrei |
856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fimmu.2021.714175/full |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1664-3224 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 12 |j 2021 |